Please assess the completion status of the following clinical trial:

Trial Title: Combination Lexapro and Massage for Treatment of Depression in Older Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. \> 60 years of age~2. Unipolar major depression as defined by Structured Clinical Interaction DSM-IV (SCID)~3. HAM-D score of \> 17 (21-item scale)\]\]~4. Not taking antidepressants for at least two weeks, 2 months for fluoxetine and MAOIs\]\]~5. Capable of giving informed consent.~Exclusion Criteria:~1. Unable to provide informed consent (e.g. severe cognitive impairment)~2. Acute medical condition or exacerbation of chronic medical condition associated with significant distress (pain, protracted fevers, etc.) and requiring active medical treatment.~3. High risk of suicide or violence as assessed by the investigator~4. Current or past history of psychosis or bipolar disorder~5. Use of psychotropic medication and/or psychotherapy outside of the study~6. (Exposure to treatment of fluoxetine or MAOIs in the previous two months; chronic use of benzodiazepine and non-benzodiazepine sedatives, antipsychotics, psychostimulants, mood stabilizing agents, codeine, steroids, anti-inflammatory agents.~7. Alternative medicine use in the preceding 30 days (e.g. acupuncture, herbs, etc.)~8. History of intolerance to massage or contraindication to massage (e.g. skin lesions that prevent direct contact by the therapist)~9. Diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder, schizotypal disorder, psychotic depression or bipolar disorders;~10. MMSE less than 22~11. Alzheimer's Disease Assessment Scale-Cognitive Subscale ³ greater than 12~12. Current drug or alcohol abuse or dependence or history of drug or alcohol abuse or dependence within the past 6 months~13. Unstable medical or neurological conditions that are likely to interfere with the treatment of depression~14. Currently on psychotropic medications including antidepressants or neuroleptics~15. Active suicidal ideation or other safety issues determined by the clinician to not be suitable for inclusion in the study

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Swedish Massage (Type: EXPERIMENTAL): Adding massage twice a week, for 8 weeks, and Lexapro in the treatment of depression.
- Light-Touch (Type: SHAM_COMPARATOR): Adding light touch twice a week, for 8 weeks, and Lexapro in the treatment of depression.

Based on this trial design, predict the completion outcome and termination type (if applicable).